Galderma Aktie
| 144,20CHF | 4,50CHF | 3,22% |
WKN DE: A407X6 / ISIN: CH1335392721
Personal
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Personal am Ende des Jahres | 5 675 | 6 355 | 6 545 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,55 | 0,57 | 0,56 | 0,00 |
Bilanz (in Mio. CHF) - Aktiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Umlaufvermögen | 1 382 | 1 394 | 1 360 | 1 670 |
| Summe Anlagevermögen | 10 072 | 10 092 | 9 136 | 9 764 |
| Summe Aktiva | 11 455 | 11 486 | 10 497 | 11 434 |
Bilanz (in Mio. CHF) - Passiva
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Summe Fremdkapital | 7 311 | 7 352 | 5 977 | 4 374 |
| Summe Eigenkapital | 4 144 | 4 134 | 4 519 | 7 060 |
| Summe Passiva | 11 455 | 11 486 | 10 497 | 11 434 |
Adresse
| Zählerweg 10, 6300 Zug | |
| Telefon | +41 (58) 455-85-92 |
| Internet | http://www.galderma.com |
Management
|
Adrian Murphy
Head-Global Operations |
|
Allison Pinkham
Chief Human Resources Officer |
|
Emil Ivanov
Head-Strategy, Investor Relations & ESG |
|
Flemming Ørnskov
Chief Executive Officer & Director |
|
Karen L. Ling
Independent Director |
|
L. Daniel Browne
Independent Director |
|
Marcus Brennecke
Director |
|
Maria Teresa Hilado
Independent Director |
|
Michael Bauer
Director |
|
Sherilyn D. McCoy
Vice Chairman |
|
Thomas Ebeling
Chairman |
|
Thomas Johannes W. Dittrich
Chief Financial Officer |